CERNER MILENNIUM POWER ORDERS
Report
- Report Number
- 1931259-2014-00007
- Event Type
- Malfunction
- Date Received
- June 27, 2014
- Date of Event
- April 14, 2014
- Report Date
- June 27, 2014
- Manufacturer
- CERNER CORP.
- Product Code
- OUG
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO, US
- Reporter Occupation
- OTHER
Narratives
CERNER DISTRIBUTED A PRIORITY REVIEW FLASH NOTIFICATION ON (B)(4) 2014 TO ALL POTENTIALLY IMPACTED CLIENT SITES. THE SOFTWARE NOTIFICATION INCLUDES A DESCRIPTION OF THE ISSUE, AN ALTERNATIVE TO PREVENT THE ISSUE FROM OCCURRING AND NOTIFICATION THAT A SOFTWARE MODIFICATION IS BEING DEVELOPED TO ADDRESS THE ISSUE FOR ALL SITE S THAT COULD BE POTENTIALLY IMPACTED. CERNER CORPORATION WILL PROVIDE A FOLLOW UP REPORT WHEN THE SOFTWARE MODIFICATION IS AVAILABLE.
THE ISSUE INVOLVES CERNER MILLENNIUM POWER ORDERS USED FOR ORDER MANAGEMENT BY PHYSICIANS AND CLINICIANS. THE ISSUE MAY OCCUR IF POWERORDERS IS DEPLOYED WITH THE IGNORE PROFILELOCK PREFERENCE SET TO 1 (ON) AT THE DEFAULT LEVEL AND SET TO 0 (OFF) AT THE NURSE UNIT OR FACILITY LEVEL. WITH THIS CONFIGURATION ALL ASPECTS OF INTERACTION CHECKING ARE NOT PERFORMED IN THE UNIT OF FACILITY INCLUDING DRUG-DUPLICATE, DRUG-DRUG, DRUG-ALLERGY, AND DRUG-FOOD INTERACTIONS FOR MEDICATIONS, CONTINUOUS INFUSIONS, AND NEW INTERMITTENT SUPPORT. PATIENT CARE COULD BE ADVERSELY AFFECTED IF PATIENT RECEIVES DUPLICATE ORDERS OF THE SAME MEDICATION, A MEDICATION TO WHICH THE PATIENT IS ALLERGIC, OR A MIX OF DRUGS THAT DUPLICATE OR REACT WITH EACH OTHER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 376419 | CERNER MILENNIUM POWER ORDERS | SOFTWARE | OUG | CERNER CORP. | 2012-01 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |